Michael Retsky
Researcher
Harvard TH Chan School of Public Health USA
USA
Biography
Michael Retsky has PhD in experimental physics from University of Chicago 1974. He made a career change to cancer research in 1980s while working at Hewlett-Packard in Colorado Springs. He became Prof of Biology at University of Colorado and later visiting Prof in Medical Oncology at University of Texas - San Antonio. He was on Judah Folkman’s staff at Harvard Medical School for 12 years during which time the dormancy research got started. Diagnosed with stage IIIc colon cancer in 1994, he was the first person to use metronomic chemotherapy. He is now on staff at Harvard TH Chan School of Public Health. With Romano Demicheli he edited a book: Perioperative Inflammation as Triggering Origin of Metastasis Development (Springer- Nature 2017). He has 3 patents pending on methods to prevent late relapses. His over 100 papers in Physics and Oncology have been cited over 2500 times.
Research Interest
Metastasis cancer